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Abstract
Epigenetic control of gene transcription is critical for normal human development and cellular differentiation. While
alterations of epigenetic marks such as DNA methylation have been linked to cancers and many other human diseases,
interindividual epigenetic variations in normal tissues due to aging, environmental factors, or innate susceptibility are poorly
characterized. The plasticity, tissue-specific nature, and variability of gene expression are related to epigenomic states that
vary across individuals. Thus, population-based investigations are needed to further our understanding of the fundamental
dynamics of normal individual epigenomes. We analyzed 217 non-pathologic human tissues from 10 anatomic sites at 1,413
autosomal CpG loci associated with 773 genes to investigate tissue-specific differences in DNA methylation and to discern
how aging and exposures contribute to normal variation in methylation. Methylation profile classes derived from
unsupervised modeling were significantly associated with age (P,0.0001) and were significant predictors of tissue origin
(P,0.0001). In solid tissues (n=119) we found striking, highly significant CpG island–dependent correlations between age
and methylation; loci in CpG islands gained methylation with age, loci not in CpG islands lost methylation with age
(P,0.001), and this pattern was consistent across tissues and in an analysis of blood-derived DNA. Our data clearly
demonstrate age- and exposure-related differences in tissue-specific methylation and significant age-associated
methylation patterns which are CpG island context-dependent. This work provides novel insight into the role of aging
and the environment in susceptibility to diseases such as cancer and critically informs the field of epigenomics by providing
evidence of epigenetic dysregulation by age-related methylation alterations. Collectively we reveal key issues to consider
both in the construction of reference and disease-related epigenomes and in the interpretation of potentially pathologically
important alterations.
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Introduction
While all somatic cells in a given individual are genetically
identical (excepting T and B cells), different cell types form highly
distinct anatomic structures and carry out a wide range of
disparate physiologic functions. The vast repertoire of cellular
phenotypes is made possible largely via epigenetic control of gene
expression, which is known to play a critical role in cellular
differentiation. Epigenetics is the study of mitotically and/or
meiotically heritable changes in gene function that cannot be
explained by changes in DNA sequence [1], and includes critical
normal processes such as X-chromosome inactivation and
genomic imprinting. Alterations in epigenetic control have been
linked to several human pathologic conditions including cancers,
and Rett, ICF, and Beckwith-Wiedemann syndromes [2–5]. The
most widely studied epigenetic mark is DNA cytosine methylation,
most often investigated in the context of CpG dinculeotides in
promoter regions which often have concentrations of CpGs known
as CpG islands. Normal cells are thought to generally maintain
CpG islands in an unmethylated state permissive to transcription
[6]. However, emerging work has established the presence of tissue
specific methylation patterns in normal tissue at these islands [7–
10]. Further, just as normal genetic variation is now understood to
be associated with a predisposition to a vast array of human
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define the underlying interindividual differences in tissue specific
methylation that lead us to an understanding of the nature of the
relationships that govern these crucial tissue specific differences.
We have previously distinguished normal and tumor tissues
using methylation profiling [12,13]. These studies demonstrated
variability in the methylation profiles of pleural mesotheliomas and
tumors of the head and neck that was, in part, attributable to
etiologically important exposures. In a similar manner, there is a
basic need for epigenetic profiling of normal tissues to more
completely characterize the normal pattern of promoter methyl-
ation variation in development, aging, and in response to common
environmental exposures such as alcohol and tobacco smoke.
Efforts to describe the methylation profiles of normal tissues are
now underway. Recent genome-wide studies of methylation in
normal human tissues have shown that DNA methylation profiles
are tissue-specific and correlated with sequence elements [8–
10,14–16]. However, while these studies are groundbreaking in
showing that tissues have different patterns of methylation, the
underlying causes and extent of tissue-specific and non-specific
interindividual variation in DNA methylation patterns remain
largely unknown. In fact, in a follow up experiment from a larger
effort, Illingworth et al. observed significant variation among
individuals when bisulfite sequencing a particular CpG island, and
suggested that larger-scale studies are required to determine the
extent of interindividual variability in methylation patterns [9].
Epigenetic variation has been hypothesized to cause underlying
differences in disease susceptibility among monozygotic twins, and
young twin-pairs have been shown to be more epigenetically
similar than older monozygotic twins [17]. Therefore, the aging
process and differences in environment have been hypothesized to
influence clinically significant changes in methylation profiles as
individuals accumulate varying exposures with age. In fact, recent
work has shown an overall trend of increased methylation
associated with older age in normal human prostate and colon
tissues in several genes [18,19]. Although an increase in promoter
methylation with aging is generally accepted, recent evidence from
Bjornsson et al. suggests a more complex picture. These authors
found both increased and decreased intra-individual global
methylation levels (enriched for promoter regions) in peripheral
blood cell DNA over time [20]. In this background, it is crucial to
more extensively characterize the contribution of aging and the
environment to tissue-specific interindividual epigenetic variation.
In this study we used Illumina’s GoldenGate methylation
platform to investigate cytosine methylation in 217 normal human
tissue specimens from 10 different anatomic sites in order to begin
to understand variation both between and within tissues across
individuals. Profiling CpG methylation of normal human tissues
allowed us to begin characterizing the role of aging and
environmental exposures in interindividual methylation variation,
as well as specific gene-loci determinant of normal tissue-
specificity. This work highlights the dynamic nature of epigen-
omes, and begins to disentangle the roles of aging, environmental
factors, and innate variability among individual epigenomic
profiles, both within, and across tissues.
Results
Unsupervised clustering
Array methylation data were first assembled for exploration and
visualization with unsupervised hierarchical clustering using
Manhattan distance and average linkage for the 500 most variable
autosomal CpG loci (Figure 1). Epigenetic profiles among these
normal tissues are strikingly different. Applying recursively
partitioned mixture modeling (RPMM) [21] to methylation data
from all autosomal CpG loci across all 217 normal human tissue
samples resulted in 23 methylation classes and their average
methylation profiles (Figure 2A). Among the 23 classes in this
model, 16 classes (70%) perfectly captured only a single tissue type
(Table 1), and methylation profile classes were a highly significant
predictor of sample tissue type (permutation P,0.0001). Further,
age was significantly associated with methylation classes
(P,0.0001). Separating samples into groups as placenta, blood,
or other solid tissue, we found a significant association between
group and methylation profile classes (P,0.0001).
Supervised clustering
Random Forests (RF) classification of all samples based on
methylation average beta values at all autosomal loci returned a
confusion matrix showing: which samples are correctly classified,
which are misclassified, and the misclassification error rate for
each sample type (Table 2). Overall, 19 samples were confused
with different tissue types, giving an overall misclassification error
rate of 8.8%, significantly lower than expected under the null
hypothesis (P,0.0001). Not unexpectedly, tissue types with larger
sample sizes showed a significantly reduced misclassification error
rates (P,0.05). The mean and standard deviation of average beta
values for all autosomal CpG loci in each tissue type, and values
for the decrease in random forest classification accuracy with locus
removal are given in Table S1. In a RF analysis that examined
whether samples could be correctly classified as placenta, blood, or
other solid tissue, no samples were misclassified (misclassification
error=0%, P,0.0001), and the mean and standard deviation of
average beta values for all autosomal CpG loci in each of placenta,
blood, or solid tissue, and values for the decrease in random forest
classification accuracy with locus removal are given in Table S2.
Author Summary
The causes and extent of tissue-specific interindividual
variation in human epigenomes are underappreciated and,
hence, poorly characterized. We surveyed over 200
carefully annotated human tissue samples from ten
anatosites at 1,413 CpGs for methylation alterations to
appraise the nature of phenotypically, and hence poten-
tially clinically important epigenomic alterations. Within
tissue types, across individuals, we found variation in
methylation that was significantly related to aging and
environmental exposures such as tobacco smoking.
Individual variation in age- and exposure-related methyl-
ation may significantly contribute to increased suscepti-
bility to several diseases. As the NIH–funded HapMap
project is critically contributing to annotating the human
reference genome defining normal genetic variability, our
work raises key issues to consider in the construction of
reference epigenomes. It is well recognized that under-
standing genetic variation is essential to understanding
disease. Our work, and the known interplay of epigenetics
and genetics, makes it equally clear that a more complete
characterization of epigenetic variation and its sources
must be accomplished to reach the goal of a complete
understanding of disease. Additional research is absolutely
necessary to define the mechanisms controlling epige-
nomic variation. We have begun to lay the foundations for
essential normal tissue controls for comparison to diseased
tissue, which will allow the identification of the most
crucial disease-related alterations and provide more robust
targets for novel treatments.
Variation in DNA Methylation
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Variation in tissue-specific methylation relative to differences
between tissue types was first explored visually. Scatter plots of
methylation values for representative samples from two different
tissueswereless well correlatedthansimilar plots of tworepresentative
samples from the same tissue type, though variation in tissue-specific
methylation was also evident (Figure S1). Tissue-specific methylation
patterns for adult blood, lung, and pleural tissue samples were then
modeled with RPMM to investigate potential associations of age and
exposures with methylation profiles. An RPMM of adult bloods
(n=30) resulted in two methylation classes (Figure 2B), and age
differed significantly by methylation class (P,0.005), though we did
not detect significant associations between methylation class and
smoking status, packyears, or alcohol consumption. An RPMM of
lung tissues (n=53) resulted in five methylation classes (Figure 2C)
where class membership was not associated with age or smoking
status. An RPMM of pleural tissues (n=18) resulted in five
methylation classes (Figure 2D), and class membership was not
associated with age; yet, an association between methylation class and
asbestos exposure approached significance (P,0.07).
Locus-by-locus analysis of exposure-related methylation
While exposures were not strongly associated with array-wide
methylation profiles, locus-specific analysis revealed several
exposure-related methylation alterations. Among pleural tissues
24 CpG loci had asbestos-related alterations in methylation, all of
which were increases in methylation (Q,0.05, Table S3). In adult
bloods, increasing packyears of smoking was significantly associ-
ated with MLH1 (Q,0.0001), and RIPK3 (Q,0.002) methylation;
and over 30 CpG loci had significantly altered methylation in
never versus ever drinkers (Q,0.05, Table S4). Among lung
tissues, smoking status (never/ever) was associated with altered
methylation at 138 CpG loci (Q,0.05, Table S5).
CpG locus–specific, age-related methylation
Given our results from RPMM and previous reports of age-
relatedincreasesinmethylationinnormaltissues[18,19,22]wenext
focused on age-related methylation at specific CpG loci. We began
by examining gene-loci that other investigators have reported to be
associated with age and found that ESR1, GSTP1, IGF2, MGMT,
MYOD1, RARB,a n dRASSF1 had significant age-associated
methylation alterations, the majority of which were increases
(P,0.05, age range .0, n=139, Table 3). Hypothesizing that
alterations in epigenetic regulatory genes or genes involved in aging
processes could lead to the observed associations between age and
methylation profiles from RPMM, we tested CpG loci in epigenetic
regulatory genes, telomere maintenance genes, and a premature
aging syndrome gene, again finding significant age related
methylation alterations (Table 3). For example, LAMB1 – involved
in subchromosome domain positioning [23] – had increased
methylation with age. Significant age-related methylation alter-
ations in telomere maintenance gene-loci TERT, ERCC1, RAD50,
and the Werner syndrome gene-locus (WRN) were also observed.
Additionally, and in contrast to the predominantly increased age
Figure 1. Unsupervised clustering of average beta values in normal human tissues. Normal tissue sample average beta values were
subjected to unsupervised hierarchical clustering based on Manhattan distance and average linkage. Each column represents a sample and each row
represents a CpG locus (500 most variable autosomal loci). Above the heatmap, colors indicate tissue type as in key. In the heat map blue=average b
of one, or methylated, and yellow=average b of zero, or unmethylated.
doi:10.1371/journal.pgen.1000602.g001
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age-related decrease in CpG methylation of the de novo methyl-
transferase DNMT3B; and unlike the vast majority of other CpGs
tested, DNMT3B_P352 was not located in a CpG island (Table 3).
Array-wide, locus-by-locus analysis of age-related
methylation
To expand the examination of age-associated methylation
alterations, we performed array-wide locus-by-locus analysis of
CpGs. For all tissues (age range .0, n=139), after correcting for
multiple comparisons, over 300 CpG loci had age-related
methylation alterations (Q,0.05, Table 4). Restricting analysis to
solid tissues (n=119) revealed over 250 CpG loci with age-related
methylation alterations (Q,0.05, Table 4). Tissue-specific locus-
by-locus analysis of age-related methylation was also performed
(tissue types with n .10), detailed in Table S6.
There is now a considerable literature that suggests that genome
structure affects both the initial placement of DNA methylation
marks in development [24] as well as protecting silenced regions
Figure 2. Recursive partitioning mixture models (RPMM) of methylation profiles in normal tissuses. Methylation average b is yellow for
unmethylated and blue for methylated. Methylation profile classes are stacked in rows separated by red lines, and class height corresponds to the
number of samples in each class. Class methylation at each CpG locus is a mean of methylation for all samples within a class. (A) Methylation profile
classes significantly differentiate all normal tissue types (n=217, P,0.0001). (B) Methylation profile classes from RPMM of adult bloods, class
membership is significantly associated with age (P,0.005, n=30). (C) Methylation profile classes from RPMM of lung tissue samples (n=53). (D)
Methylation profile classes from RPMM of pleural samples (n=18).
doi:10.1371/journal.pgen.1000602.g002
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that genomic structure can affect the changes we observed in
normal methylation, we assessed the potential effects of CpG
island status on age-related methylation, with the hypothesis that
there may be differential susceptibility to changes in DNA
methylation in queried regions defined as canonical islands
compared to those not in CpG islands. A CpG island is defined
according to Takai and Jones [26], as a region of 200 bp with a
GC content of .55% with an observed to expected ratio of CpG
.0.65. This analysis used Generalized Estimator Equations
(GEE), which are robust to within-person correlation and to the
influence of aberrant observations [27], and estimated mean
associations between age and methylation by CpG island status.
Among all solid tissues (n=119), the direction of correlation
between age and methylation differed dependent upon whether
the CpG was found in a CpG island. Loci in CpG islands had
significantly positive correlations between methylation and aging,
while loci not in CpG islands had significant losses of methylation
with aging (P=7.0E-04; Table 5). Similar trends were observed for
other solid tissue types; age-related associations with methylation
were significantly positive for loci in CpG islands for pleural
tissues, and significantly negative for loci not in islands in brain
tissues (Table 5). Interestingly, among adult blood samples,
significantly negative correlations between age and methylation
alterations were observed irrespective of CpG island status
(P=5.2E-05, Table 5).
To investigate CpG-dependent correlations between aging and
methylation in more detail we clustered CpGs (rather than
samples) with RPMM (aiming to examine classes of CpGs with
similar methylation profiles in more detail), grouping CpGs with
similar methylation into eight separate classes. The CpG island
status of all loci was plotted, and illustrates the well known
tendency for CpGs located in islands to be unmethylated, while
non-island CpGs tend to be methylated (Figure 3). We again used
Table 1. Recursively partitioned mixture model-derived CpG methylation profile class membership significantly predicts tissue
type.
Methylation
class # Total n
n(%)
Bladder
Adult
Blood Brain Cervical
Infant
blood
Head &
Neck Kidney Lung Placenta Pleura
Small
Intestine
1 28 3 (11) - - - - - 2 (7) 12 (43) - 8 (29) 3 (11)
2 24 - - - - - - - 19 (79) - 5 (21) -
3 23 - - - - - - - 20 (87) - 2 (9) 1 (4)
4 2 ---2 (100) ----- --
5 - 6 6 ---- -6 (100) --- --
7 5 --1 ( 2 0 ) - -4 ( 8 0 ) --- --
4 12 2 (14) - 2 (14) 1 (7) - - 2 (29) 2 (14) - 2 (14) 1 (7)
9 2 - - - - - - - - 1 (50) 1 (50) -
1 0 - 1 1 1 8 ---- ----18 (100) --
1 2 - 1 8 5 6 ---- 56 (100) ---- --
19 - 20 30 - 30 (100) -- ----- --
21 -22 8 - - 8 (100) - ----- --
2 3 2 --1 ( 5 0 ) - -1 ( 5 0 ) --- --
*Permutation test for association between tissue type and methylation profile class P,0.0001.
doi:10.1371/journal.pgen.1000602.t001
Table 2. Normal tissue CpG methylation-based random forests classification confusion matrix.
Bladder
Adult
blood Brain Cervix
Infant
blood
Head &
Neck Kidney Lung Placenta Pleura
Small
intestine
Sample
type n
Classification
Error
B l a d d e r 3 ------2 - -- 5 4 0 %
Adult blood - 30 - ------ -- 3 00 %
Brain - - 10 - - 2 - - - - - 12 17%
Cervix - - - - - 2 - 1 - - - 3 100%
Infant blood - - - - 55 - - - - - - 55 0%
Head & Neck - - - - - 10 - 1 - - - 11 9%
K i d n e y - -----5 1 - -- 6 1 7 %
L u n g - ------5 2 - 1 - 5 32 %
Placenta - - - -----1 9-- 1 90 %
P l e u r a - ------5 - 1 3 - 1 82 8 %
Small intestine - - - ----4 - -1 5 8 0 %
Overall misclassification error: 8.8% (P,0.0001)
doi:10.1371/journal.pgen.1000602.t002
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GENE_CpG
In CpG
island All Samples
a Solid Tissues Lung Blood Pleura Head & Neck Brain
n=139 n=110 n=52
c n=29
c n=18 n=11
c n=10
d
P-value P-value P-value P-value P-value P-value P-value
ESR1_P151 yes ,0.01 ,0.005 ,0.001 ,0.02
GSTP1_E322 yes ,0.02
GSTP1_P74 yes ,0.001
GSTP1_seq yes ,0.002
IGF2_P36 yes ,0.05 ,0.02 ,0.04
IGF2_E134 yes ,0.02 ,0.02
b
MGMT_P281 yes 0.05
b
MYOD1_E156 yes ,0.02
MYOD1_P50 yes ,0.01
b
RARB_E114 yes ,0.05 ,0.02
RARB_P60 yes 0.05 ,0.02
RASSF1_E116 yes ,0.05
b ,0.03
RASSF1_P244 yes ,0.01
b ,0.02
DNMT1_P100 yes ,0.02
b ,0.05
b
DNMT3B_P352 no ,0.0001
b ,0.05
b ,0.001
b
HDAC1_P414 yes ,0.01
b ,0.05
b ,0.01
HDAC5_E298 yes ,0.05
b
HDAC7A_P344 no ,0.0001 ,0.002
HDAC11_P556 yes ,0.05
LAMB1_E144 yes ,0.05 ,0.01 ,0.02
ERCC1_P354 yes ,0.005
b
ERCC1_P440 yes ,0.01
b ,0.05
b ,0.0001
b
RAD50_P191 yes ,0.001 ,0.05 ,0.02
b
TERT_P360 yes ,0.03
WRN_P969 yes ,0.0001 ,0.0002
aAll samples with age range ? 0.
bDecreased methylation with increasing age.
cOne sample.
dTwo samples missing age data.
*CpG loci tested, with no age association: ESR1_E298, IGF2_P1036, MGMT_P272, SFRP1_E398 & P157, TERT_E20, WRN_E57.
doi:10.1371/journal.pgen.1000602.t003
Table 4. Summary statistics of global CpG locus-by-locus age vs. methylation association tests.
Sample type n Age range Mean SD n loci Q,0.05*
Positive correlation n
(%)
Negative correlation n
(%) n loci P,0.05
All samples
a 139 14–89 60.1 16 295 120 (41) 175 (59) 424
Solid tissues 110 14–89 60 17.3 274 137 (50) 137 (50) 393
Brain
b 10 14–52 34.5 11.1 38 6 (32) 13 (68) 269
Lung
c 52 22–89 66.8 12.3 8 3 (38) 5 (62) 155
Head & Neck 11 49–80 66.2 7.9 1 1 (100) - 93
Blood
c 29 47–81 60 10.3 0 - - 109
Pleura 18 38–77 58.3 11.3 0 - - 146
*False discovery rate corrected P-value.
aAll samples with age range .0.
bTwo samples.
cOne sample missing age data.
doi:10.1371/journal.pgen.1000602.t004
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between age and methylation and plotted the estimates with their
95% confidence intervals. In a class-specific model for solid tissue
samples, there was a positive correlation between age and
methylation in classes whose loci were predominantly located in
CpG islands (P=1.9E-05, Figure 3A). The tissue specific analysis
of pleura demonstrated that classes rich in CpG island loci had
significant age-associated increases in methylation (P=2.3E-08,
Figure 3B). Interestingly, the pattern of class-specific correlations
between age and methylation in adult bloods was similar to those
for solid tissue types, though the correlation between age and
methylation was shifted towards the negative such that there was a
significant decrease in age-related methylation among loci not in
CpG islands (P=6.3E-06, Figure 3C). Lung tissues displayed a
similar pattern of class-specific correlations between age and
methylation, and the strength of these correlations approached
statistical significance (P=0.13, Figure 3D). Finally, both brain,
and head and neck samples demonstrated increased age-associated
methylation in classes rich in CpGs island loci, and decreases in
age-associated methylation in classes rich in loci not in CpG
islands (P=7.0E-04, P=5.2E-08, Figure 3E and 3F, respectively).
Array validation and independent confirmation
Bisulfite modified DNA pyrosequencing was performed to
validate array results. Array average beta values were significantly
correlated with pyrosequencing percent methylation for sequenced
array target CpGs; RARA_P176 (P=0.003), DNMT3B_P352
(P=0.008), and LIF_P383 (P=3.0E-06, Figure S2). Consistent
with array-based results, increased RARA_P176-local methylation
was associated with reported asbestos exposure in pleural samples
(n=16, P=0.10, Figure 4A). To confirm the observed associations
between age or smoking packyears with methylation, specific loci
were sequenced in array samples (n=28) and an independent set
of control blood DNAs (total n=112). Sequencing
DNMT3B_P352 both validated the association between decreased
methylation and aging, and confirmed it in an independent
population (P=0.03, n=112, Figure 4B). Similarly, the associa-
tion between LIF_P383 methylation and packyears smoked from
array results (P,0.02) was validated by pyrosequencing (P,0.02,
n=112, Figure 4C). In addition, pyrosequencing FZD9_E458-
local CpGs confirmed the association between increased methyl-
ation and aging (P,0.001, n=112, Figure 4D).
Discussion
Epigenetic patterning and maintenance are of paramount
importance for normal cellular functioning and identity. Hence,
pursuing the annotation of normal human tissue-specific epigen-
omes is an important and necessary endeavor. However, such a
project is considerably more challenging than sequencing the
genome because of the tissue-specific and dynamic nature of
epigenomes. Thus, a more complete understanding of what
constitutes a normal epigenome, and the degree to which
epigenomes vary (in a tissue dependent fashion) based on aging
and the environment has the potential to dramatically improve the
success of studies of epigenetic alterations in disease. Hence, our
work characterized methylation of phenotypically important CpG
loci across several human tissue types, elucidating interindividual
tissue-specific variation in methylation profiles and the contribu-
tion of CpG island context to age associated methylation
alterations. This work increases our appreciation for the dynamic
nature of the epigenome, and begins to define basic tenets to
follow in pursuit of both constructing reference epigenomes and
elucidating epigenetic alterations truly indicative of disease states.
Using recursively-partitioned mixture modeling and random
forests approaches, we differentiated tissues based on CpG
methylation profile, consistent with other recent studies conduct-
ing genome-wide DNA methylation profiling [8–10,15,16]. These
studies used high resolution methylation data and together have
now shown that tissues have distinct methylation profiles. This
novel and consistent body of work has, however, not addressed
exposures in relation to interindividual variations in methylation.
Not only do our findings confirm that tissue-specific epigenetic
patterns can be readily defined with a targeted promoter-based
CpG array, but they identify target sets of gene-loci most
consistently capable of differentiating tissue types.
Factors known to contribute to methylation alterations include
carcinogen exposures, inflammation, and diet. Several carcinogen
exposures such as tobacco, alcohol, arsenic, and asbestos have
been associated with methylation-induced gene-inactivation in
various human cancers including bladder cancer, head and neck
squamous cell carcinoma, and mesothelioma [28–33]. It is
therefore reasonable to suggest that various and potentially
accumulating exposures throughout life may directly or indirectly
lead to methylation alterations and impact disease susceptibility.
Carcinogens are well known to induce genetic abnormalities that
can lead to clonal selection and expansion in normal appearing
tissues (termed ‘‘field effect’’). Hence, the association of carcinogen
exposures with the occurrence of altered methylation at pheno-
typically important loci may arise as a consequence of altered
(‘‘initiated’’) clones. Our data suggest that large epigenetic changes
occur in normal appearing tissues, and the relationship of these
changes to companion genetic changes is of interest to study in the
future.
Table 5. The direction of age-related methylation coefficients
is dependent on CpG island status.
Tissue
a Age-related methylation
CpG island status estimate (CpGs)
b 95% CI P
Solid tissues (n=119)
Not in island 20.021 (22) 20.040 20.001
In CpG island 0.024 (4) 0.009 0.039 7.0E-04
Adult blood (n=29)
Not in island 20.026 (23) 20.040 20.012
In CpG island 20.018 (22) 20.033 20.003 5.2E-05
Lung (n=52)
Not in island 20.020 (22) 20.042 0.001
In CpG island 0.004 (1) 20.015 0.024 0.16
Pleura (n=18)
Not in island 20.002 (20) 20.036 0.032
In CpG island 0.059 (11) 0.023 0.096 0.004
Head and Neck (n=11)
Not in island 20.009 (21) 20.049 0.030
In CpG island 0.025 (4) 20.072 0.122 0.77
Brain (n=10)
Not in island 20.068 (26) 20.117 20.019
In CpG island 0.051 (8) 20.031 0.134 0.006
aTissue n is for samples with available age data.
bEstimate is per decade (,n CpGs altered/decade; positive indicates
methylation with age, negative for loss of methylation with age).
doi:10.1371/journal.pgen.1000602.t005
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methylation in normal tissues were motivated in large part by
studies of methylation in cancer [34]. An early report from Issa et
al. described an association between aging colonic mucosa and
estrogen receptor methylation [35]. In general, trends of global
(repeat element) hypomethylation and promoter hypermethylation
found in cancer also have been observed in normal tissues with
aging [36]. In recent reports of age-related methylation in normal
human prostate and colon tissues, several CpG-island-containing
genes were reported to have age-related increases in methylation
[18,19]. Our results confirm these findings and, in addition,
document that age-related alterations in these CpG loci are tissue-
dependent. More importantly, our examination of loci with
previously reported age-associated methylation alterations, in
conjunction with reports from others, suggested that the
relationship between aging and promoter CpG methylation is
complex. For example, using restriction-landmark genome
scanning of over 2000 CpG loci in T lymphocytes comparing
newborns, middle age, and elderly people, Tra et al. reported that
29 loci had age-related methylation alterations, with 23 loci
displaying increased methylation with age and 6 decreasing with
age [37]. In addition, measuring intra-individual global methyl-
Figure 3. The direction of correlations for age associated methylation alterations differ dependent upon CpG island status. For (A–
F), the top plot is the estimate of mean regression coefficients for age associated methylation (by decade), and its 95% confidence interval from GEE
for each CpG RPMM class. The middle plot is of CpGs clustered with RPMM into eight classes for each group of samples. The bottom plot indicates
the CpG island status for each locus (where magenta=CpG island locus, green=non-CpG island locus). (A) Estimates of class-specific age-associated
methylation among all solid tissues (n=119), RPMM clustering of CpGs, and CpG island status. Age-associated methylation is significantly increased
among classes with a high prevalence of CpG-island loci (P=2.3E-08). (B) Estimates of class-specific age-associated methylation among blood samples
(n=29), RPMM clustering of CpGs, and CpG island status. Age-associated methylation is significantly decreased among classes with a high prevalence
of non-CpG-island loci (P=6.3E-06). (C) Estimates of class-specific age associated methylation among pleural tissues (n=18), RPMM clustering of
CpGs, and CpG island status. Age-associated methylation is significantly increased among classes with a high prevalence of CpG-island loci (P=2.3E-
08). (D) Estimates of class-specific age-associated methylation among lung tissues (n=52), RPMM clustering of CpGs, and CpG island status. (E)
Estimates of class-specific age-associated methylation among brain tissues (n=11), RPMM clustering of CpGs, and CpG island status. Age-associated
methylation is significantly increased for the predominantly CpG island loci in class 3, and significantly decreased among classes with a high
prevalence of non-CpG-island loci (P=7.0E-04). (F) Estimates of class-specific age associated methylation among head and neck tissues (n=10),
RPMM clustering of CpGs, and CpG island status. Age-associated methylation is significantly decreased among classes with a high prevalence of non-
CpG-island loci (P=5.2E-08).
doi:10.1371/journal.pgen.1000602.g003
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increased and decreased methylation levels dependent on the
individual, with over 50% of participants exhibiting .5% change
in methylation [20].
Stratifying our data on CpG-island status of loci, we showed
that both the direction and strength of correlation between age
and methylation were largely dependent upon CpG island status.
More specifically, we found a propensity for CpG-island loci to
Figure 4. Bisulfite pyrosequencing confirmation of age and environmental exposure–related methylation alterations observed in
array results. Each plot displays the gene transcription start site and surrounding CpGs are indicated by tick marks where the array CpG tick mark
has a filled circle on top, and the sequenced CpGs are surrounded by a box. (A) Distribution of mean bisulfite pyrosequencing percent methylation
for RARA_P176 and five downstream CpGs (79 bases total) stratified by known exposure to asbestos in DNA from pleural samples (n=16) confirms
the observation from array results of increased methylation at this locus among individuals with a known asbestos exposure (P=0.10). (B) Mean
bisulfite pyrosequencing percent methylation of DNMT3B_P352 and two downstream CpGs (30 bases total) in adult bloods run on the array and an
independent set of controls plotted versus age (P=0.03, rho=––0.18, n=112). (C) Mean bisulfite pyrosequencing percent methylation of LIF_P383
and two downstream CpGs (41 bases total) in adult bloods run on the array and an independent set of controls plotted versus smoking packyears
(P=0.01, rho=0.24, n=112). (D) Mean bisulfite pyrosequencing percent methylation of FZD9_E458 and five downstream CpGs (25 bases total) in
adult bloods run on the array and an independent set of controls plotted versus age (P=7.0E-04, rho=0.29, n=112).
doi:10.1371/journal.pgen.1000602.g004
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methylation with age. Our data are consistent with the literature
that has demonstrated age-related increases in methylation at
gene-loci found within CpG islands [18,19,22], as well as the
findings of Tra et al. and Bjornsson et al. who showed bi-modal age-
related methylation in normal tissues. A direct comparison, by
examination of the data of Bjornsson et al., indicated that a high
percentage of their top 50 most age-altered loci (all decreases in
methylation) are not located in CpG islands; among 24 of 30
autosomal CpGs in their Table 1 (where CpG island status can be
identified by readers), only 5/24 (21%) are located in CpG islands,
whereas 70% would be expected. Our results from blood samples
corroborate their findings, and extend them to demonstrate similar
trends in multiple other tissue types, where the strongest negative
correlation between age and methylation occurs at CpGs which
are not in CpG islands, and the strongest positive correlation
between age and methylation occurs at loci in CpG islands.
The observed pattern of age associated methylation was
irrespective of tissue-type, suggesting a common mechanism or
dysregulation to explain these alterations. Reduced fidelity of
maintenance methyltransferases with aging is one potential
explanation for age related decreases in methylation; while age
related increases in methylation could potentially reflect the
accumulation of stochastic methylation events over time. As the
examined tissues do not have a pathologic phenotype, methylated
CpGs in these cells may not indicate dramatic functional
consequences upon gene expression. However, the (in part
selective) accumulation of alterations without readily detectable
functional consequences should not be interpreted as biologically
insignificant. Age-related drift of normal epigenomes without
prominent changes in gene expression may nonetheless confer
significantly increased risk of conversion to a pathologic phenotype
by enhancing both the likelihood and frequency of methylation
events that ultimately result in aberrant expression or altered
genomic stability. For example, in the context of acquired ‘‘non-
functional’’ CpG methylation in the promoter region of an aged
individual, continued stochastic methylation events (e.g. ‘‘methyl-
ation spreading’’) increase the chance of methylation induced
silencing at that promoter (or silencing of another locus through
action at a distance via silencing of other important regions such as
enhancers), and hence, progression to a pathologic phenotype.
Certainly, this hypothesis is especially plausible for the many
diseases of aging. Alternatively, aberrant CpG methylation that
silences a gene on a single allele may not appear to have a
functional consequence if the complementary allele can provide
compensatory expression. As a result, for example, clusters of
cellular clones with mono-allelic gene expression could contribute
to an increased risk of progression to a pathologic phenotype (e.g.
loss of the 2
nd functional allele). Future population-based studies
addressing the potential of quantifying age and/or exposure
associated methylation alterations indicative of disease risk are
necessary.
We have provided clear evidence of interindividual variation in
tissue–specific methylation related to aging and environmental
exposures at disease-relevant CpGs across 10 normal human tissue
types. We have demonstrated both general and tissue specific
alterations, uncovered a CpG island context-dependent direction-
ality to age associated methylation alterations, and provided a
novel path for examining the mechanistic basis of these alterations.
By enumerating the methylation status of a panel of cancer-related
genes known to stably control transcription in normal tissues, we
have also afforded important controls for comparison to diseased
tissues, potentially aiding in identification of the most critical
alterations in specific diseases and providing more robust targets
for novel treatments. Importantly, we have also begun to
disentangle the contributions of aging and environmental factors
to methylation alterations in normal tissues. Uncovering age and
exposure-related methylation changes and their clear contextual
dependence is an important contribution to our basic understand-
ing of epigenetic maintenance as it relates to both aging and the
pathologic process, provides a potential avenue to pursue clinically
useful biomarkers, as well as to identify novel markers of disease
susceptibility.
Methods
Study samples
Normal human tissues were assembled by a collaborative, multi-
institutional network of investigators conducting molecular
epidemiologic studies of human cancer. Tissues were obtained
through Institutional Review Board approved studies already
underway at these institutions, or were obtained from the National
Disease Research Interchange (NDRI, Philadelphia, PA). Briefly,
normal brain tissues (n=12) were contributed by the Wiencke lab
at UCSF through the San Francisco Adult Glioma Study [38].
Normal lung tissues (n=49) were obtained from adjacent non-
tumor portions of lung in patients treated for NSCLC [39] or from
the NDRI from non-diseased individuals at autopsy (n=4).
Peripheral blood DNA was obtained from controls enrolled in a
study of bladder cancer (n=15) [40], controls enrolled in a study
of head and neck cancer (n=15) [41], and newborn infants
(n=55) [42]. Non-tumorigenic pleural samples (n=18) were
obtained from grossly disease-uninvolved regions of incident
mesothelioma [28]. Head and neck anatomic sites (n=11),
bladder (n=5), kidney (n=6), and small intestine (n=5) were
obtained from the NDRI, all from individuals with no gross
diseases or tumors of the obtained tissues. Non-pathologic placenta
samples (n=19) were obtained as residual tissues from control
infant term births as part of an ongoing hospital-based case-control
study of intrauterine growth restriction at Women and Infants
Hospital in Providence RI. All tissues obtained from patients with
disease (lung, pleura) were histologically confirmed as normal by
independent study pathologist review of tissue samples prior to
DNA extraction.
Methylation analysis
Fresh frozen tissue and whole blood DNA was extracted using
the QIAamp DNA mini kit according to the manufacturer’s
protocol (Qiagen, Valencia, CA). DNA was modified by sodium
bisulfite to convert unmethylated cytosines to uracil using the EZ
DNA Methylation Kit (Zymo Research, Orange, CA) according to
the manufacturer’s protocol. Illumina GoldenGate methylation
bead arrays were used to simultaneously interrogate 1505 CpG
loci associated with 803 cancer-related genes. Bead arrays have a
similar sensitivity as quantitative methylation-specific PCR and
were run at the UCSF Institute for Human Genetics, Genomics
Core Facility according to the manufacturer’s protocol and as
described by Bibikova et al [43].
Pyrosequencing
Quantification of cytosine percent methylation was performed
by pyrosequencing bisulfite-converted DNA using the PyroMark
MD pyrosequencing system (Biotage). Specific pyrosequencing
primers were designed to amplify array CpG sites and as many
downstream CpGs as conditions permitted (2 to 5 additional) using
Biotage Assay Design Software v1.0.6.
All PCR reactions were carried out in 25 ml, utilized Qiagen
Hot Star Taq polymerase, 56Q solution (except FZD9), and 106
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95uC1 5 9, (95uC3 0 0,4 5 uC (55uC for RARA)3 0 0,7 2 uC1 9) 645
cycles, and 72uC5 9. Final reaction primer concentration for PCR
and sequencing was 0.3 mM, primer details are in Table S7. All
PCR reactions included a no template control, unmodified DNA
control, and 7 standardized percent methylation controls (0%,
15%, 25%, 45%, 65%, 75%, and 100%) derived from Qiagen
EpiTect PCR control DNA set samples. Sequencing reactions
used 10 ml of PCR product and were run according to
instrument/manufacturer protocols (Biotage).
Statistical analysis
Data assembly. Data were assembled with BeadStudio
methylation software from Illumina (SanDiego, CA). All array
data points are represented by fluorescent signals from both
methylated (Cy5) and unmethylated (Cy3) alleles, and methylation
level is given by b=(max(Cy5, 0))/(|Cy3|+|Cy5|+100), the average
methylation (b) value is derived from the ,30 replicate methylation
measurements. Raw average beta values were analyzed without
normalization as recommended by Illumina. Each array CpG is
annotated with the gene name followed by the CpG location (P for
promoter, E for exonic, or (rarely) seq to reference a specific
sequence) and its physical distance from the transcription start site.
At each locus for each sample the detection P-value was used to
determine sample performance; 5 samples (2%), had detection P-
values .1.0E-05 at more than 25% of CpG loci and were removed
from subsequent analysis. Similarly, CpG loci with a median
detection P–value .0.05 (n=8, 0.5%), were eliminated from
analysis. Finally, all CpG loci on the X chromosome were excluded
from analysis. The final dataset contained 217 samples and 1413
CpG loci associated with 773 genes. The manufacturer
recommended CpG island designation of array CpGs was used
and follows the definition of CpG island in [26].
Unsupervised clustering. Subsequent analyses were carried
out using the R software [44]. For exploratory and visualization
purposes, hierarchical clustering was performed using R function
hclust with Manhattan metric and average linkage. To discern and
describe the relationships between CpG methylation and tissue
type (sample clustering), and the relationships between CpGs with
coordinate methylation (CpG clustering), a modified model-based
form of unsupervised clustering known as recursively partitioned
mixture modeling (RPMM) was used as described in [21] and as
used in [33]. This approach, a model-based version of HOPACH
[45], and Dynamic Tree Cutting [46], built classes of samples
based upon profiles of methylation with data using a mixture of
beta distributions to recursively split samples into parsimoniously
differentiated classes [47–50]. For sample clustering the number of
classes was determined by recursively splitting the data via 2-class
models with Bayesian information criterion (BIC) used at each
potential split to decide whether the split was to be maintained or
abandoned [21,51,52]. For CpG clustering the same approach
was used and models were subsequently pruned to eight terminal
classes. Permutation tests (running 10,000 permutations) were used
to test for association with methylation class by generating a
distribution of the test statistic for the null distribution for
comparison to the observed distribution. For continuous
variables, the permutation test was run with the Kruskal-Wallis
test statistic. For categorical variables we used the standard chi-
square statistic for testing association between two categorical
variables.
Random forests. The R Package was also used to build
classifiers with the Random Forest (RF) approach. RF is a tree-
based classification algorithm similar to Classification and
Regression Tree (CART) [53,54] and was performed on CpG
average beta values using RandomForest R package version 4.5–
18 by Liaw and Wiener. RF builds each individual tree by taking a
bootstrap sample (sampling with replacement) of the original data
and on average about 1/3 of the original data are not sampled (out
of bag or OOB). Those sampled are used as the training set to
grow the trees (here 500,000), and the OOB data are used as the
test set. At each node of the tree, a random sample of m out of the
total M variables is chosen and the best split is found among the m
variables. We utilized the default value for m in the Random Forest
R package, !M (!1413=38). The misclassification error rate is the
percentage of time the RF prediction is incorrect.
Locus-by-locus analysis. Associations between covariates
and methylation at individual CpG loci were tested with a
generalized linear model. The beta-distribution of average beta
values was accounted for with a quasi-binomial logit link with an
estimated scale parameter constraining the mean between 0 and 1,
in a manner similar to that described by Hsuing et al. [55]. When
testing for associations between age and CpG methylation,
samples with an age range=0 (placenta, infant bloods) were
excluded. Tissue types with ,10 samples (bladder, kidney, and
small intestine) were not analyzed independently. CpG loci where
an a priori hypothesis existed were tested separately, such as those
that have been previously associated with aging in normal tissues
[18,19], as well as genes involved in epigenetic regulation,
telomere maintenance (selected with GO term lists), and the
premature aging syndrome (Werner) gene WRN. Array-wide
scanning for CpG loci associations with sample type or covariate
used false discovery rate estimation and Q–values computed by the
qvalue package in R [56].
To test the hypothesis that there are associations of age and
exposure with methylation, we constructed measures of partial
methylation sets, in analogy with global DNA methylation, which
is measured on repeats [57]. Specifically, we hypothesize that only
CpGs that have limited functional significance (within a tissue) are
allowed to acquire methylation alterations , and that these events
are stochastic; consequently, only CpGs whose methylation varies
across specimens of the same type will show evidence of
association with age or exposure, but individual CpG methylation,
as a binary event with low individual probability, may demonstrate
correlation too weak to detect and validate in a subsequent sample.
On the other hand, average methylation over a defined set of
CpGs will have increased power to measure the totality of such
events with the set. To define such sets, we conducted RPMM
clustering on the CpGs (rather than specimens) over all specimens
of a defined tissue type, pruning the resulting tree to 8 classes.
Within each class we averaged methylation values to form a single,
CpG-class-specific partial methylation statistic. For each set, we fit
a quasi-binomial model [55] expressing the logit mean partial
methylation for each class as a linear function of age or exposure;
standard errors were computed using generalized estimating
equations (GEE) [27], from which confidence intervals were
constructed. Furthermore, to properly account for multiple
comparisons in a statistically efficient manner, we tested the
omnibus null hypothesis of no association in any of the 8 partial
methylation classes using a Wald test statistic constructed from the
GEE estimates and robust variance-covariance matrix. To test a
similar methylation hypothesis while distinguishing between loci in
CpG-Islands and those that are not in CpG islands, we followed a
similar methodology, replacing the 8 CpG RPMM class
designation with CpG island designation.
Pyrosequencing analysis. S e q u e n c i n gd a t aw e r ep r o c e s s e d
using Pyro Q-CpG software v1.0.9 (Biotage) under default analysis
parameters and exported for subsequent analysis in R software [44].
Associations between pyrosequencing percent methylation values and
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exposures were tested with a Spearman correlation test.
Supporting Information
Figure S1 Pairwise plots comparing average beta values (A)
between all blood and all head & neck samples, (B) individual
blood sample versus an individual head & neck sample,
comparisons within tissue type between individual samples for
(C) blood and (D) head & neck. Average beta value scatterplots
between tissue types indicate significant differences between
tissues, and scatterplots within tissue type indicate relative
similarity in the presence of interindividual variation. A) Mean
of average betas for all blood samples (n=30) versus mean of
average betas for all head and neck samples (n=11), indicates
relatively high variability between tissue types, R2=0.84. B)
Representative blood sample 1 average betas versus representative
head and neck sample 1 average betas indicate similarly high
variability between tissue types at the individual sample level,
R2=0.87. C) Representative blood sample 2 versus representative
blood sample 3 indicates relative similarity between individuals
within a tissue type in the presence of interindividual variation,
R2=0.97. D) Representative head and neck sample 1 versus
representative head and neck sample 2 indicates relative similarity
between individuals within a tissue type in the presence of
interindividual variation, R2=0.96.
Found at: doi:10.1371/journal.pgen.1000602.s001 (0.07 MB TIF)
Figure S2 Bisulfite pyrosequencing mean percent methylation
across all CpGs measured for RARA, DNMT3B, and LIF versus
their respective CpG of interest on the array. Bisulfite pyrosequen-
cing mean percent methylation across all CpGs measured for
RARA, DNMT3B, and LIF versus their respective CpG of
interest on the array. A) Mean bisulfite pyrosequencing percent
methylation across array target CpG RARA_P176 and 5
downstream CpGs plotted versus Illumina GoldenGate methyla-
tion array average beta demonstrates a significant correlation
between sequencing and array methylation (P=0.03; n=16). B)
Mean bisulfite pyrosequencing percent methylation across array
target CpG DNMT3B_P352 and 2 downstream CpGs plotted
versus Illumina GoldenGate methylation array average beta
demonstrates a significant correlation between sequencing and
array methylation (P=0.02; n=28). Mean bisulfite pyrosequen-
cing percent methylation across array target CpG LIF_P383 and 2
downstream CpGs plotted versus Illumina GoldenGate methyla-
tion array average beta demonstrates a significant correlation
between sequencing and array methylation (P=7.7E-08; n=28).
Found at: doi:10.1371/journal.pgen.1000602.s002 (0.04 MB TIF)
Table S1 Autosomal CpG locus mean (sd) of average beta and
values for the decrease in random forest classification accuracy
with locus removal, all tissues.
Found at: doi:10.1371/journal.pgen.1000602.s003 (0.68 MB
XLS)
Table S2 Autosomal CpG locus mean (sd) of average beta and
values for the decrease in random forest classification accuracy
with locus removal, for solid tissues, blood, and placenta.
Found at: doi:10.1371/journal.pgen.1000602.s004 (0.29 MB
XLS)
Table S3 CpG loci with significantly altered methylation by
reported asbestos exposure in pleural samples (n=18).
Found at: doi:10.1371/journal.pgen.1000602.s005 (0.04 MB
DOC)
Table S4 CpG loci with significantly altered methylation in
never versus ever alcohol drinkers in blood (n=29).
Found at: doi:10.1371/journal.pgen.1000602.s006 (0.05 MB
DOC)
Table S5 CpG loci with significantly altered methylation by
smoking in lung tissue (n=53).
Found at: doi:10.1371/journal.pgen.1000602.s007 (0.13 MB
DOC)
Table S6 Top 100 CpG loci associated with age by tissue type.
Found at: doi:10.1371/journal.pgen.1000602.s008 (0.84 MB
DOC)
Table S7 Pyrosequencing assay primers.
Found at: doi:10.1371/journal.pgen.1000602.s009 (0.05 MB
DOC)
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